I
Inivata
Biotech & Life Sciences · Morrisville, United States · Founded 2014
Clinical cancer genomics company harnessing the emerging potential of circulating DNA analysis MoreLess
Inivata is a pioneering company in the field of liquid biopsy, a technology that extracts key genomic information from a simple blood test to revolutionize cancer care. The company primarily serves patients with advanced Non-Small Cell Lung Cancer (NSCLC) and high-grade ovarian carcinomas (HGOC). Operating in the healthcare and biotechnology markets, Inivata collaborates with medical institutions and pharmaceutical companies to provide cutting-edge diagnostic solutions. Its business model revolves around the development and commercialization of liquid biopsy assays, which are used for detecting residual disease and recurrence in cancer patients. Revenue is generated through the sale of these diagnostic tests and through strategic partnerships and collaborations, such as the one with Maverick Therapeutics. Inivata's innovative approach and commitment to improving patient outcomes make it a leader in its field.
Keywords: liquid biopsy, cancer care, genomic insights, NSCLC, HGOC, diagnostic solutions, biotechnology, healthcare, residual disease, Maverick Therapeutics.
Company overview
Inivata company information
The essential company record, classifications and operating signals in one place.
- Status
- Acquired
- Founded
- 2014
- Headquarters
- Morrisville, United States
- Employees
- 36
- Open positions
- None listed
- Dealroom signal
- 62.9
Valuation & funding
Inivata funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| ACQUISITIONOther financing | May 2021 | $390M | $500M | NeoGenomics Laboratories | — |
| SERIES COther financing | Feb 2021 | $35M | $140M | Farallon Capital Management · Janus Henderson Investors · IP Group · Soleus Capital | — |
| SERIES COther financing | May 2020 | $25M | $100M | NeoGenomics Laboratories | — |
| SERIES BOther financing | Mar 2019 | $53M | $210M | Cambridge Innovation Capital · Woodford Investment Management · IP Group · Johnson & Johnson Innovation | — |
| SERIES AOther financing | Jan 2016 | $42M | $166M | Woodford Investment Management · Imperial Innovations · Cambridge Innovation Capital · Johnson & Johnson | — |
| SERIES AOther financing | Sep 2014 | Johnson & Johnson · Imperial Innovations · Cambridge Innovation Capital | — | ||
| SPINOUTOther financing | Jan 2014 | University of Cambridge | ↗ |
Financials
Revenue, earnings and profit over time
Reported history and available estimates. Estimated years are marked “E”; sparse fields are left blank rather than inferred.
| Year | Revenue | Growth | EBITDA | Margin |
|---|---|---|---|---|
| 2026 | $854K | 0% | −$25M | -2884.4% |
| 2025 | $854K | 0% | −$25M | -2884.4% |
| 2024 | $854K | 0% | −$25M | -2884.4% |
| 2023 | $854K | 0% | −$25M | -2884.4% |
| 2022 | $854K | 0% | −$25M | -2884.4% |
| 2021 | $854K | 0% | −$25M | -2884.4% |
| 2020 | $854K | — | −$25M | -2884.4% |
Growth signals
Inivata website traffic
Latest recorded traffic for Inivata is 760 monthly website visits, down 45.7% over the last three months. Inivata's team declined 71.2% over the past year.
Comparisons
Inivata compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
Talent graph
Inivata's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Inivata has talent and traffic
In the news
Latest news about Inivata
Recent press, funding announcements, and product moves mentioning Inivata — open to read from the original sources.
Market sentiment
What the market is saying about Inivata
An AI-synthesized read of the highest-engagement posts about Inivata on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Inivata’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.